ClinicalPURSUIT Case Studies
In this section you can find case studies where various GVT solutions have been successfully implemented.
QLT Inc., Bio-technology
QLT Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies. Their research and development efforts are focused on pharmaceutical products in the fields of ophthalmology and dermatology. QLT hired GVT to produce a patient registry application to help them understand how their drugs and therapies were progressing and performing in the marketplace.
If you treat patients with Visudyne therapy, you may have wondered how your outcomes compare with those of other doctors. Now there's an easy way to tell: You can enter your verteporfin treatment data at the GVT Patient Registry, a Web-based, secure database including data from more than 100 practices.
When a patient has age-related macular degeneration (AMD), we base our treatment decisions on various factors, including:
Type of AMD: Exudative or nonexudative
Type of choroidal neovascularization (CNV): Predominantly classic, occult or minimally classic
Lesion location: Subfoveal, juxtafoveal or extrafoveal
The last factor, size, has gained much attention as we fine-tune our treatment plans. Read on for the latest on this important consideration and more information about the GVT Patient Registry.